Decision Diagnostics Corp (DECN)

[Raffis]

SEC CONTRADICTED ITSELF BY PRESUMING AND WRONGFULLY STIPULATING MULTIPLE DISTORTIONS AGAINST BERMAN. THE SEC DID NOT CONDUCT FULL, IMPARTIAL INQUIRIES. AT ONE POINT THE SEC DISTORTED INFO, SUCH THAT THEY WRONGFULLY AND LUDICROUSLY ACCUSED BERMAN OF “CONSTRUING THE FDA, PRE-EUA ACKNOWLEDGEMENT AS AN APPROVAL.” BERMAN CLEARLY NEVER MADE ANY SUCH REPRESENTATION. AND BERMAN WOULD NEVER MAKE ANY SUCH CLAIM. THE SEC FILED DEFECTIVE INSTRUMENTS AND BERMAN AND PHARMA TECH AND THE BIO ALL KNOW THE FDA RULES, WHICH THEY ARE IN COMPLIANCE, WITHOUT ANY BREACH OF ANY ESTABLISHED LAWS, POLICIES AND/OR RULES. THE SEC FILED BASELESS AND ILLOGICAL ALLEGATIONS.